Clinical Trials

Accrual Status
Limit to SWOG Trials

654 Results

Active Filters

Status Trial Number Title Sort descending Activated Closed Accrual Phase Published
Closed S0720 Phase II Adjuvant NSCLC 11/15/2008 5/15/2012 100% Published
Closed S0536 Phase II Carboplatin, Paclitaxel, Cetuximab and Bevacizumab in Adv. NSCLC 8/15/2006 9/15/2007 100% Published
Closed S0709 Phase II Carboplatin/Paclitaxel/Erlotinib vs Erlotinib Alone in Advanced NSCLC 12/1/2008 9/15/2014 54% Published
Closed S0941 Phase II Cholangiocarcinoma with Sorafenib + Erlotinib 4/15/2010 9/15/2011 73% Published
Closed SWOG-9350 Phase II Disseminated Malignant Melanoma 8/1/1994 11/13/1996 39% Published
Closed SWOG-7916 Phase II Evaluation of Gallium Nitrate in Metastatic Urological Malignancies: Testicular, Bladder, Prostate and Kidney 7/20/1979 1/19/1984 Published
Closed SWOG-8304 Phase II Evaluation of L-Alanosine in Metastatic Carcinoma of the Breast 5/27/1983 5/4/1984 Published
Closed SWOG-8519 Phase II Evaluation of Methyl-Glyoxal Bis- Guanylhydrazone (MGBG) in Patients With Advanced Bladder Cancer 1/1/1986 5/15/1989 Published
Closed S0805 Phase II HyperCVAD + Dasatinib with or without Allo SCT for Ph+ ALL 9/1/2009 100% Published
Closed S0115 Phase II Melphalan + Auto PBSC Trans. for High Risk MM / Amyloidosis - BMT Study 1/1/2004 10/15/2010 95% Published
Closed S1108 Phase II MLN8237 in Peripheral T-Cell NHL 10/28/2011 6/6/2013 100% Published
Closed S0703 Phase II Older Previously Untreated Non-M3 AML 12/1/2008 93% Published
Closed S0432 Phase II Previously Untreated AML in Patients of Age 70 or Older 9/15/2004 2/21/2006 100% Published
Closed S0301 Phase II Previously Untreated Non-M3 AML in Patients of Age 56 or Older 10/1/2003 12/15/2006 100% Published
Closed S0722 Phase II RAD001 in MPM 12/1/2008 9/15/2011 100% Published
Closed S0530 Phase II Relapsed or Refractory ALL 10/1/2006 8/1/2008 100% Published
Closed S0434 Phase II Relapsing/Resistant Myeloma Previously Treated with Bortezomib 3/15/2006 58% Published
Closed S0605 Phase II Revlimid Untreated Non-M3, 5q- AML and >= Age 60 6/15/2006 7/1/2010 91% Published
Closed S0933 Phase II RO4929097 in Adv Melanoma 10/28/2010 11/15/2011 45% Published
Closed S0816 Phase II Stage III-IV Hodgkin's: FDG-PET Imaging Study 7/1/2009 12/1/2012 100% Published
Scroll Table